Expanding the differential for diarrhea beyond Clostridium difficile.
A research team from the Netherlands turns to deep sequencing technology to detect hepatitis C virus resistant variants.
What’s the 411 on 2-1-1?
A quick debrief of the week’s top FDA approvals, FDA authorizations, or other infectious disease pipeline developments from the past week.
Biofilms are an emerging clinical problem despite the fact that most clinicians don’t even think of biofilms when managing infections.
Men who have sex with men who seek out sexual partners online are more likely to report sexually transmitted infections, including syphilis, gonorrhea, and chlamydia.
The globalization of antibiotic stewardship programs is necessary in the fight against antibiotic resis­tance.
With IV drug use accounting for 60% of new infections, treatment for individuals in this population is necessary to stave off new infections.
This In the Literature piece explores if we can mitigate some of the adverse reactions that are being seen in obese patients who receive vancomycin through AUC-dosing.
Infections transmitted by these bloodsucking species are on the rise worldwide.
Amesh A. Adalja, MD, FIDSA argues that a bill being considered in the Pennsylvania state legislature will ultimately result in increased antibiotic resistance and will set back the clock for finding appropriate treatments for Lyme disease.
Many health care facilities are looking to expand the use of broad-spectrum sporicidal disinfectants beyond patient isolation rooms to better address the role of the environment in pathogen transmission and acquisition.
If FDA approved, this 5-in-1 investigational candidate could provide the broadest meningococcal serogroup coverage.
If resources and funds were unlimited, what would the ideal stewardship program look like?
Contagion® Editorial Advisory Board member, Khalid Eljaaly, PharmD, BCPS, CAPP, discusses key updates in the Infectious Diseases Society of America and the American Thoracic Society recommendations.
The National Institutes of Health has awarded a 4-year, $4.8 million grant to the University of Arizona to speed up the development of delta-CPS1, a vaccine candidate to fight valley fever.
Health officials in China have confirmed a case of bubonic plague in a herdsman from the Inner Mongolia district, triggering increased prevention measures throughout the region.
As COVID-19 evolves, learning how to live with a virus that has become endemic will have its challenges, but medical science will help the public be able to accept it.
In 2017, lower respiratory tract infections linked with influenza were responsible for an estimated 145,000 deaths worldwide.
We review current and emerging treatment options for infections caused by the difficult-to-treat, intrinsically multidrug-resistant organism Stenotrophomonas maltophilia.
This virus has multiple facets and highlights a need for real-time learning.
“A bite bug in the belly.”
Despite having emerged as either the third or fourth leading cause of blood stream infections in the United States, the threat of multi-drug resistant Candida species remains an underappreciated concern.
Parallels between the recent Zika epidemic in Brazil and the HIV pandemic in the 1980s, stress the importance of improving responses to public health crises.
An understanding of the limitations in their functionality and strategies for more appropriate applications are necessary for clinicians.
Government agencies and researchers continue to monitor the potentially troubling trend.
A survey of 571 US hospitals regarding practices used to prevent Clostridium difficile infection indicates that nearly half of the facilities appear to not be taking steps to prevent the infection that kills nearly 30,000 people and sickens hundreds of thousands more each year, despite strong evidence that these steps work.